These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 9589220

  • 41. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T, Seeman P, Kuroiwa M, Nishi A.
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [Abstract] [Full Text] [Related]

  • 42. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test.
    Zarrindast MR, Sahebgharani M, Burnham WM.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):509-14. PubMed ID: 15589391
    [Abstract] [Full Text] [Related]

  • 43. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM, Kreipke CW, Walker PD.
    Neuroscience; 2006 Dec; 137(2):505-17. PubMed ID: 16289829
    [Abstract] [Full Text] [Related]

  • 44. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX, Walters JR.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [Abstract] [Full Text] [Related]

  • 45. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P, Abercrombie ED.
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [Abstract] [Full Text] [Related]

  • 46. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I, Kehr J, Andbjer B, Fuxe K.
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [Abstract] [Full Text] [Related]

  • 47. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B, Frenois F, Zold CL, Chetrit J, Murer MG, Gonon F.
    Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
    [Abstract] [Full Text] [Related]

  • 48. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 49. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW, Zhang SP, Qin ZH, Weiss B.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [Abstract] [Full Text] [Related]

  • 50. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C, Nikkhah G, Cunningham MG, Björklund A.
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [Abstract] [Full Text] [Related]

  • 51. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats.
    Drake JD, Kibuuka LN, Dimitrov KD, Pollack AE.
    Pharmacol Biochem Behav; 2013 Apr; 105():26-33. PubMed ID: 23369985
    [Abstract] [Full Text] [Related]

  • 52. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
    Berridge KC, Aldridge JW.
    Synapse; 2000 Sep 01; 37(3):205-15. PubMed ID: 10881042
    [Abstract] [Full Text] [Related]

  • 53. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM, Fairfax DF, Henry P, N-Marandi S, Khan RF, Gupta SK, Mishra RK.
    Synapse; 2004 Dec 01; 54(3):156-63. PubMed ID: 15452862
    [Abstract] [Full Text] [Related]

  • 54. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.
    Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP.
    Neurotox Res; 2003 Dec 01; 5(5):329-38. PubMed ID: 14715452
    [Abstract] [Full Text] [Related]

  • 55. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959.
    Zhen X, Goswami S, Friedman E.
    Pharmacol Biochem Behav; 2005 Apr 01; 80(4):597-601. PubMed ID: 15820529
    [Abstract] [Full Text] [Related]

  • 56. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 01; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 57. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation.
    Rowlett JK, Mattingly BA, Bardo MT.
    Synapse; 1993 Jun 01; 14(2):160-8. PubMed ID: 8332946
    [Abstract] [Full Text] [Related]

  • 58. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors.
    Canales JJ, Iversen SD.
    Synapse; 2000 Jun 15; 36(4):297-306. PubMed ID: 10819907
    [Abstract] [Full Text] [Related]

  • 59. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
    Asin KE, Bednarz L, Nikkel A, Perner R.
    J Pharmacol Exp Ther; 1995 Jun 15; 273(3):1483-90. PubMed ID: 7791123
    [Abstract] [Full Text] [Related]

  • 60. Persistent spontaneous oral dyskinesias in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates.
    Huang NY, Kostrzewa RM, Li C, Perry KW, Fuller RW.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):268-76. PubMed ID: 8996206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.